American Association for the Advancement of Science, Science Translational Medicine, 588(13), 2021
DOI: 10.1126/scitranslmed.aaz6804
Full text: Unavailable
HDAC8 inhibition elicits durable responses to immune checkpoint blockade by improving adaptive immune responses through enhancer reprogramming.